Clinical Trials Browser

Phase 3 × Recruiting × Leukemia, Myelomonocytic, Chronic × Clear all

NCT06647862 2025-11-25

IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic